Abstract
Drugs of the benzodiazepine class have been introduced in several areas of clinical practice over the past years (Zbinden and Randall 1967; Greenblatt and Shader 1974; Bellantuono et al. 1980). Among their various valuable properties is their potent effect against experimental convulsions and various forms of epilepsy in man (Banziger 1965; Gastaut et al. 1971; Browne and Penry 1973). This property was noted during early animal and clinical studies with chlordiaz-epoxide and diazepam (Randall et al. 1960,1968; Zbinden and Randall 1967), the prototype drugs of this class (Sternbach and Reeder 1961). Subsequent studies with newly developed benzodiazepines revealed similar anticonvulsant activities, differing mainly in quantitative rather than qualitative aspects (Greenblatt and Shader 1974; Garattini et al. 1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen MD, Greenblatt DJ, Arnold JD (1979) Single- and multiple-dose kinetics of estazolam, a triazolo benzodiazepine. Psychopharmacology 66: 267–274
Ashton D, Wauquier A (1979) Effects of some anti-epileptic, neuroleptic and gabaminergic drugs on convulsions induced by d,l-allylglycince. Pharmacol Biochem Behav 11: 221–226
Ballabio M, Caccia S, Garattini S, Guiso G, Zanini MG (1981) Antileptazol activity and kinetics of clobazam and TV-desmethyl-clobazam in the guinea-pig. Arch Int Pharmacodyn Ther 253: 192–199
Banziger RF (1965) Anticonvulsant properties of chlordiazepoxide, diazepam and certain other 1,4-benzodiazepines. Arch Int Pharmacodyn Ther 154: 131–136
Banziger RF, Hane D (1967) Evualation of a new convulsant for anticonvulsant screening. Arch Int Pharmacodyn Ther 167: 245–249
Barazi S, Bonini M (1980) Determination de onze dérivés des benzodiazépines en solution acétonique par chromatographic en phase gaseuse utilisant un detecteur specifique azote. J Chromatogr 202: 473–477
Bartosek I, Kvetina J, Guaitani A, Garattini S (1970) Comparative study of nitrazepam metabolism in perfused isolated liver of laboratory animals. Eur J Pharmacol 11: 378–382
Bellantuono C, Reggi V, Tognoni G, Garattini S (1980) Benzodiazepines: clinical pharmacology and therapeutic use. Drugs 19: 195–219
Belvedere G, Tognoni G, Frigerio A, Morselli PL (1972) A specific, rapid and sensitive method for gas-chromatographic determination of methyl-oxazepam in small samples of blood. Anal Lett 5: 531–541
Billingsley ML, Kubena RK (1978) The effects of naloxone and picrotoxin on the sedative and anti-conflict effects of benzodiazepines. Life Sci 22: 897–906
Braestrup C (1981) Biochemical effects of anxiolytics. In: Hoffmeister F, Stille G (eds) Psychotropic agents. Springer, Berlin Heidelberg New York, pp 293–319 (Handbook of experimental pharmacology, vol 55/2)
Braestrup C, Squires RF (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H) diazepam binding. Proc Natl Acad Sci USA 74: 3805–3809
Braestrup C, Squires RF (1978) Brain specific benzodiazepine receptors. Br J Psychiatry 133: 249–260
Briley MS, Langer SZ (1978) Influence of GABA receptor agonists and antagonists on the binding of 3H-diazepam to the benzodiazepine receptor. Eur J Pharmacol 52: 129–132
Browne TR, Penry JK (1973) Benzodiazepines in the treatment of epilepsy. A review. Epilepsia 14: 277–310
Buckett WR (1980) Intravenous bicuculline in mice facilitates in vivo evaluation of drugs affecting GABA like mechanisms. Br J Pharmacol 68: 177–178
Caccia S, Ballabio M, Guiso G, Zanini MG (1979) Gas-liquid chromatographic determination of clobazam and N-desmethyl-clobazam in plasma. J Chromatogr 164: 100–105
Caccia S, Carli M, Garattini S, Pogessi E, Rech R, Samanin R ( 1980 a) Pharmacological activities of clobazam and diazepam in the rat. Relation to drug brain levels. Arch Int Pharmacodyn Ther 243: 275–283
Caccia S, Guiso G, Garattini S (1980 b) Brain concentrations of clobazam and N-des-methyl-clobazam and antileptazol activity. J Pharm Pharmacol 32: 295–296
Caccia S, Guiso G, Samanin R, Garattini S (1980 c) Species differences in clobazam metabolism and antileptazol effect. J Pharm Pharmacol 32: 101–103
Caccia S, Ballabio M, Garattini S (1981) Relationship between camazepam, N-methyl-oxazepam and oxazepam brain concentration and antileptazol effect in the rat. J Pharm Pharmacol 33: 185–187
Cano JP, Bailie AM, Viala A (1975) Determination of bromazepam in plasma with an internal standard by gas liquid chromatography. Arzneimittelforsch 25: 1012–1016
Cano JP, Guintrand J, Aubert C, Viala A (1977) Determination of flunitrazepam, des-methylflunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard. Arzneimittelforsch 27: 338–342
Chang RSL, Snyder SH (1978) Benzodiazepine receptors: labeling in intact animals with [3H] flunitrazepam. Eur J Pharmacol 48: 213–218
Costa E, Guidotti A, Mao CC ( 1975 a) Evidence for involvement of GABA in the action of benzodiazepines. Studies on rat cerebellum. In: Costa E, Greengard PG (eds) Mechanism of action of benzodiazepines. Raven, New York, pp 113–130
Costa E, Guidotti A, Mao CC, Suria A (1975 b) New concepts on the mechanism of action of benzodiazepines. Life Sci 17: 167–186
De Silva JAF, Bekersky I (1974) Determination of clonazepam and flunitrazepam in blood by electron-capture gas-liquid chromatography. J Chromatogr 99: 447–460
De Silva JAF, Kaplan J (1966) Determination of 7-bromo-l,3-dihydro-5-(2-pyridyl)-2H-l,4–benzodiazepine-2-one (RO-5-3350) in blood by gas-liquid chromatography. J Pharm Sci 55: 1278–1283
Dingledine R, Iversen LL, Breuker E (1978) Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol 47: 19–27
Ekonomov AL, Rodionov AP, Zherdev VP, Vikhlyaev YUI (1979) 7-Bromo-5-(2′-chlorophenyl)-l,3-dihydro-2H-l,4-benzodiazepin-2-one(l), a new tranquillizing agent: metabolism in rats. Xenobiotica 9: 503–510
Fielding S, Hoffmann I (1979) Pharmacology of anti–anxiety drugs with special reference to clobazam. Br J Clin Pharmacol 7: 7–15
Fuccella LM, Bolcioni G, Tamassia V, Ferrario L, Tognoni G (1977) Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 12: 383–386
Garattini S, Marcucci F, Mussini E (1969) Gas chromatographic analysis of benzodiazepines. In: Porter R (ed) Gas chromatography in biology and medicine. Churchill, London, pp 161–172
Garattini S, Mussini E, Marcucci F, Guaitani A (1973) Metabolic studies on benzodiazepines in various animal species. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 75–97
Garattini S, Marcucci F, Mussini E (1977) The metabolism of pharmacokinetics of selected benzodiazepines. In: Usdin E, Forrest IS (eds) Psychotherapeutic drugs, part 2. Applications. Dekker, New York, pp 1039–1087
Garattini S, Caccia S, Mennini T (1981) Pharmacological and biochemical studies on benzodiazepines. In: De Las Heras FG, Vega S (eds) Medicinal chemistry advances. Pergamon, Oxford, pp 171–178
Garattini S, Caccia S, Carli M, Mennini T (1981) Notes on kinetics and metabolism of benzodiazepines. Adv Biosci 31: 351–364
Gastaut H, Naquet R, Poire R, Tassinari CA (1965) Treatment of status epilepticus with diazepam (valium). Epilepsia 6: 167–182
Gastaut H, Courjon J, Poire R, Weber M (1971) Treatment of status epilepticus with a new benzodiazepine more active then diazepam. Epilepsia 12: 197–214
Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice. Raven, New York Greenblatt DJ, Shader RI (1978) Prazepam and lorazepam, two new benzodiazepines. N Engl J Med 299: 1342–1344
Greenblatt DJ, Shader RI, Koch-Weser J (1975) Flurazepam hydrochloride. Clin Pharmacol Ther 17: 1–14
Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM (1978) Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet 3: 381–394
Greenblatt DJ, Divoll M, Moschitto LJ, Shader RI (1981) Electron-capture gas chromatographic analysis of the triazolobenzodiazepines, alprazolam and triazolam. J Chromatogr 225: 202–207
Grimes RM, Alton KB, Shaw C (1973) Metabolism of a 1,5-benzodiazepine ORF 8063 in man. Pharmacologist 15: 254
Haefely W, Kulcsar A, Mohler H, Pieri L, Pole P, Schaffner R (1975) Possible involvement of GABA in the central actions of benzodiazepines. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven, New York, pp 131–151
Haefely W, Pieri L, Pole P, Schaffner R (1981) General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister F, Stille G (eds) Psychotropic agents. Springer, Berlin Heidelberg New York, pp 13–262 (Handbook of experimental pharmacology, vol 55/2)
Hines LR (1981) Toxicology and side–effects of anxiolytics. In: Hoffmeister F, Stille G (eds) Psychotropic agents. Springer, Berlin Heidelberg New York, pp 359–393 (Handbook of experimental pharmacology, vol 55/2)
Hunkeler W, Mohler H, Pieri L, Pole P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290: 514–516
Johnston GA, Mitchell JF (1971) The effect of bicuculline, metrazol, picrotoxin and strychnine on the release of [3H]GABA from rat brain slices. J Neurochem 18: 2441–2446
Kamioka T, Nakayoma I, Akijama S, Takagi H (1972) Pharmacological studies on 10- chloro-11b-(2-chlorophenyl)-2,3,5,6,7,11b-hexahydrobenzo-[6,7]-l,4-diazepino[5,4-b] oxazol-6-one(CS-370), a new psychosedative agent. Arzneimittelforsch 22: 884–891
Kanai Y (1974) The biotransformation of 8-chloro-6-phenyl-4H-S-triazolo[4,3,9] [l,4]benzodiazepine(D-40TA) a new central depressant, in man, dog and rat. Xenobiotica 4: 441–456
Kaplan SA, Jack ML (1981) Pharmacokinetics and metabolism of anxiolytics. In: Hoffmeister F, Stille G (eds) Psychotropic agents. Springer, Berlin Heidelberg New York, pp 321–358 (Handbook of experimental pharmacology) vol 55/2
Killam EK, Suria A (1980) Antiepileptic drugs. Benzodiazepines. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic drugs: mechanisms of action. Raven, New York, pp 597–615
Kitagawa H, Esumi Y, Kurosawa S, Sekine S, Yokoshima T (1979) Metabolism of 8-chloro-6-(O-chlorophenyl)-l-methyl-4H-5′-triazolo[4,3-a] [1,4]benzodiazepine, triazolam, a new central depressant. II. Identification and determination of metabolites in rats and dogs. Xenobiotica 9: 429–439
Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B (1979) Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11: 457–462
Klotz U (1981) Determination of bromazepam by gas-liquid chromatography and its application for pharmacokinetic studies in man. J Chromatogr 222: 501–506
Ladinsky H, Consolo S, Bellantuono C, Garattini S (1981) Interaction of benzodiazepines with known and putative neurotransmitter in the brain. In: Van Praag HM (ed) Brain mechanisms and abnormal behavior-chemistry. Dekker, New York, pp 825–858 (Handbook of biological psychiatry, part 4 )
Lanzoni J, Airoldi L, Marcucci F, Mussini E (1979) Gas Chromatographic determination of chlorodesmethyldiazepam and lorazepam in rats and mice. J Chromatogr 168: 260–265
Lembeck F, Beubler E (1977) Convulsion induced by hyperbaric oxygen: inhibition by phenobarbital, diazepam and baclofen. Naunyn Schmiedebergs Arch Pharmacol 297: 47–51
Lippa AS, Klepner CA, Yunger L, Sano MC, Smith WV, Beer B (1978) Relationship between benzodiazepine receptors and experimental anxiety in rats. Pharmacol Biochem Behav 9: 853–856
Löscher W (1979) 3-Mercaptopropionic acid: Convulsant properties, effects on enzymes of the γ-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. Biochem Pharmacol 28: 1397–1407
Macdonald RL, Barker JL (1978) Specific antagonism of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons. A common mode of convulsant action. Neurology 28: 325–330
Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3: 72–91
Möhler H, Okada T (1977) Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortex. Life Sci 20: 2101–2110
Möhler H, Okada T, Heitz P, Ulrich J (1978) Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci 22: 985–996
Morin AM, Tanaka I A, Wasterlain CG (1981) Norharman inhibition of [3H] diazepam binding in mouse brain. Life Sci 28: 2257–2263
Morselli PL, Cassano GB, Placidi GF, Muscettola GB, Rizzo M (1973) Kinetics of the distribution of 14C-diazepam and its metabolites in various areas of cat brain. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 129–143
Nakajima R, Hattori C, Nagawa Y (1971 a) Structure-activity relationship of S-triazolo-1,4-benzodiazepines in central nervous depressant action. Jpn J Pharmacol 21: 489–495
Mao CC, Guidotti A, Costa E (1975) Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepam. Naunyn Schmiedebergs Arch Pharmacol 289: 369–378
Marcucci F, Fanelli R, Mussini E, Garattini S (1970) Further studies on species difference in diazepam metabolism. Eur J Pharmacol 9: 253–256
Marcucci F, Guaitani A, Fanelli R, Garattini S (1971) Metabolism and anticonvulsant activity of diazepam in guinea pigs. Biochem Pharmacol 20: 1711–1713
Martin IL, Candy JM (1978) Facilitation of benzodiazepine binding by sodium chloride and GABA. Neuropharmacology 17: 993–998
Martin IL, Candy JM (1980) Facilitation of specific benzodiazepine binding in rat brain membrane fragments by a number of anions. Neuropharmacology 19: 175–179
Mattson RH (1972) Other antiepileptic drugs. The benzodiazepines. In: Woodbury DM,
Penry JK, Schmidt RP (eds) Antiepileptic drugs. Raven, New York, pp 497–516
Meldrum BS, Chapman AG, Horton RW (1979) Clobazam: anticonvulsant action in animal models of epilepsy. Br J Clin Pharmacol 7: 59–60
Mennini T, Cotecchia S, Caccia S, Garattini S (1982) Benzodiazepines: relationship between pharmacological activity in the rat and in vivo receptor binding. Pharmacol Biochem Behav 16: 529–532
Nakajima R, Take Y, Moriya R, Saji Y, Yui T, Nagawa Y (1971 b) Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo[4,3a] [1,4] benzodiazepine (D-40 TA) and its 1-methyl analogue (D-65 MT). Jpn J Pharmacol 21: 497–516
Nakajima R, Saji Y, Kozato Y, Mikoda R, Tanayama S, Nagawa Y (1973) Dissociative change in anti-aggressive and muscle relaxant actions of S-triazolobenzodiazepine (D-40 TA) by repeated administration and phenobarbital pretreatment and its relation to metabolism. J Takeda Res Lab 32: 264–274
Olsen RW, Leeb-Lundberg F (1981) Convulsant and anticonvulsant drug binding sites related to GABA-regulated chloride ion channels. In: Costa E, Di Chiara G, Gessa GL (eds) GABA and benzodiazepine receptors. Raven, New York, pp 93–102
Paul SM, Syapin PJ, Paugh BA, Moncada V, Skolnick P (1979) Correlation between benzodiazepine receptor occupation and anticonvulsant effect of diazepam. Nature 281: 688–689
Paul SM, Marangos PJ, Skolnick P, Goodwin FK (1980) Brain-specific benzodiazepine receptors and putative endogenous “benzodiazepine-like” compounds. Psychopharmacol Bull 16: 9–20
Pinder RM, Brogden RN, Speight TM, Avery GS (1976) Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 12: 321–361
Randall LO, Kappell B (1973) Pharmacological activity of some benzodiazepines and their metabolites. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 27–51
Randall LO, Schallek W, Heise GA, Keit EF, Bagdon RE (1960) The psychosedative properties of methaminodiazepoxide. J Pharmacol Exp Ther 129: 163–171
Randall LO, Schallek W, Scheckel C, Banziger R, Moe RA (1968) Zur Pharmakologie des neuen Psychopharmakons 7-chlor-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepin (RO-5-4556). Arzneimittelforsch 18: 1542–1545
Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Muller WE, Wollert U (1981) Benzodiazepine antagonism by hormone and other β-carbolines in vitro and in vivo. Eur J Pharmacol 70: 409–416
Rudzik AD, Hester JB, Tang AH, Straw RN, Friis W (1973) Triazolobenzodiazepines, a new class of central nervous system-depressant compounds. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 285–297
Rupp W, Badian M, Christ O, Hajdu P, Kulkarni RD, Taeuber K, Uihlein M, Bender R, Vanderbeke O (1979) Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol 7: 51–57
Sadee W, Van Der Kleijn E (1971) Thermolysis of 1,4-benzodiazepines during gas chromatography and mass spectroscopy. J Pharm Sci 60: 135–137
Schallek W, Schlosser W, Randall LO (1972) Recent developments in the pharmacology of the benzodiazepines. Adv Pharmacol Chemother 10: 119–183
Schlosser W, Franco S (1979) Reduction of γ-aminobutyric acid ( GABA)-mediated transmission by a convulsant benzodiazepine. J Pharmacol Exp Ther 211: 290–295
Schlosser W, Zavatsky E, Kappell B, Sigg EB (1973) Antagonism of bicuculline and RO-5-3663 by diazepam. Pharmacologist 15: 162
Schwartz MA (1973) Pathways of metabolism of the benzodiazepines. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 53–74
Schwartz MA, Postma E (1970) Metabolism of flurazepam, a benzodiazepine, in man and dog. J Pharm Sci 59: 1800–1806
Skellern GG, Meier J, Knight BI, Whiting B (1978) The application of HPLC to the determination of some 1,4-benzodiazepines and their metabolites in plasma. Br J Clin Pharmacol 5: 483–487
Smith MT, Eadi MJ, O’Rourke Brophy T (1981) The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 19: 271–278
Soubrie P, Simon P (1978) Comparative study of the antagonism of bemegride and picrotoxin on behavioural depressant effects of diazepam in rats and mice. Neuropharmacology 17: 121–125
Speth RC, Wastek GJ, Johnson PC, Yamamura HI (1978) Benzodiazepine binding in human brain: characterization using [3H]flunitrazepam. Life Sci 22: 859–866
Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266: 732–734
Stein L, Wise CD, Berger BD (1973) Antianxiety action of benzodiazepines: decrease in activity of serotonin neurons in the punishment systems. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 299–326
Stein L, Wise CD, Belluzzi JD (1975) Effects of benzodiazepines on central serotonergic mechanisms. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven, New York, pp 29–44
Sternbach LH, Reeder E (1961) Quinazolines and 1,4-benzodiazepines. II. The rearrangement of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide into 2-amino derivatives of 7-chloro-5-phenyl-3/M,4-benzodiazepine-4-oxide. J Organic Chem 26: 1111–1118
Tallman JF, Mallorga P, Thomas JW, Gallager DW (1981) Benzodiazepine binding sites: properties and modulation. In: Costa E, Di Chiara G, Gessa GL (eds) GABA and benzodiazepine receptors. Raven, New York, pp 9–18
Ticku MK, Van Ness PC, Haycock JW, Levy WB, Olsen RW (1978) Dihydropicrotoxinin binding sites in rat brain: comparison to GABA receptors. Brain Res 150: 642–647
Van Der Kleijn E, Vree TB, Guelen PJM (1977) 7-Chloro-1,4-benzodiazepines: diazepam, desmethyldiazepam, oxydiazepam, oxydesmethyldiazepam (oxazepam) and chlordiaz-epoxide. In: Usdin E, Forrest IS (eds) Psychotherapeutic drugs, part 2. Application. Dekker, New York, pp 997–1037
Volz M, Christ O, Kellner HM, Kuch H, Fehlhaber HW, Gantz D, Hajdu P, Cavagna F (1979) Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol 7: 41–50
Vree TB, Lenselink B, Van Der Kleijn E (1977) Determination of flunitrazepam in body fluids by means of high-performance liquid chromatography. J Chromatogr 143:530– 534
Vree TB, Baars AM, Hekster YA, Van Der Kleijn E (1979) Simultaneous determination of diazepam and its metabolites AT-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography. J Chromatogr 162: 605–614
Williamson MJ, Paul SM, Skolnick P (1978) Demonstration of [3H]diazepam binding to benzodiazepine receptors in vivo. Life Sci 23: 1935–1940
Young AB, Snyder SG (1973) Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci USA 70: 2832–2836
Young AB, Zukin SR, Snyder SH (1974) Interaction of benzodiazepines with central nervous glycine receptors: possible mechanism of action. Proc Natl Acad Sci USA 71: 2246–2250
Zbinden G, Randall LO (1967) Pharmacology of benzodiazepines: laboratory and clinical correlations. Adv Pharmacol 5: 213–251
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Caccia, S., Garattini, S. (1985). Benzodiazepines. In: Frey, HH., Janz, D. (eds) Antiepileptic Drugs. Handbook of Experimental Pharmacology, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69518-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-69518-6_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69520-9
Online ISBN: 978-3-642-69518-6
eBook Packages: Springer Book Archive